$556.53
0.34% yesterday
Nasdaq, Sep 09, 10:00 pm CET
ISIN
US75886F1075
Symbol
REGN

Regeneron Pharmaceuticals Stock News

Neutral
GlobeNewsWire
about 10 hours ago
NEW YORK, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C.
Neutral
GlobeNewsWire
about 20 hours ago
Late-breaking data from exploratory analyses at WCLC show Libtayo plus chemotherapy demonstrates a more than double five-year overall survival rate of 19.4%, compared to 8.8% with chemotherapy alone
Neutral
Seeking Alpha
one day ago
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN ) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 7:00 AM EDT Company Participants Christopher Fenimore - Executive VP of Finance & CFO Leonard Schleifer - Co-Founder, President, CEO & Co-Chairman Marion McCourt - Executive Vice President of Commercial Conference Call Participants Terence Flynn - Morgan Stanley, Research Div...
Positive
The Motley Fool
3 days ago
Investors haven't been kind to Intuitive Surgical (ISRG 2.67%) and Regeneron Pharmaceuticals (REGN 0.96%) this year. Both healthcare leaders have encountered company-specific issues that have led to sell-offs.
Neutral
GlobeNewsWire
5 days ago
TARRYTOWN, N.Y., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that it will now present at the Morgan Stanley 23rd Annual Global Healthcare Conference at 7:00 a.m. ET on Monday, September 8, 2025.
Neutral
Seeking Alpha
5 days ago
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN ) Wells Fargo 20th Annual Healthcare Conference 2025 September 4, 2025 9:30 AM EDT Company Participants Ryan Crowe - Senior Vice President of Investor Relations & Strategic Analysis Marion McCourt - Executive Vice President of Commercial Conference Call Participants Mohit Bansal - Wells Fargo Securities, LLC, Research Division Presentation Mohit Bans...
Neutral
Seeking Alpha
6 days ago
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN ) Cantor Global Healthcare Conference 2025 September 3, 2025 1:35 PM EDT Company Participants Ryan Crowe - Senior Vice President of Investor Relations & Strategic Analysis Christopher Fenimore - Executive VP of Finance & CFO Conference Call Participants Carter Gould - Cantor Fitzgerald & Co., Research Division Presentation Carter Gould Research Analy...
Positive
24/7 Wall Street
7 days ago
I'm a massive fan of Dr. Michael Burry, the man played by Christian Bale in The Big Short, not only because he's made some incredible (albeit high-stakes) calls, even in the years that followed his big bet against the U.S.
Show more news

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today